Literature DB >> 8596098

Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group.

T Lang1, V Nicaud, B Darné, B Rueff.   

Abstract

OBJECTIVES: To improve blood pressure control among hypertensive ( > 140/90 mmHg) excessive alcohol drinkers.
DESIGN: Fourteen worksite physicians were randomised onto an intervention group and a control group. The intervention was based on training the worksite physicians and follow up of those hypertensive subjects defined as excessive drinkers. Follow up was based on self monitoring of alcohol consumption by the subject, in view of the results of their gamma glutamyl transferase (GGT) activity determination.
SETTING: Fourteen workplaces in France - mainly in the industrial sector.
SUBJECTS: Altogether 15 301 subjects were screened by the 14 physicians: 129 of these were included in the study. MAIN OUTCOME MEASURES: This was the difference between the initial systolic blood pressure (SBP) and the SBP one year later (delta BP). Secondary criteria were the difference between the initial and final diastolic blood pressure (delta DBP) and delta BP at two years; antihypertensive treatment; state alcohol consumption (delta AC); delta GGT; and body mass index (delta BMI).
RESULTS: The decrease in SBP levels was significantly larger in the intervention group than in the control group: at one year, delta SBP values were -11.9 (15.6) mmHg and -4.6 (13.8) respectively (p < 0.05). This benefit was still observed after two years of follow up (-13.8 (17.4) mmHg v -7.5 (14.2) mmHg (p < 0.05)). No difference was observed in DBP. The percentage of treated subjects did not differ between groups. At one year, delta AC was larger in the intervention group (-2.8 (5.2) U/d) than in the control group (-1.6 (3.4) (p < 0.1)). delta GGT and delta BMI did not differ between the two groups. A weak positive correlation was observed between delta AC and delta SBP (r = 0.16).
CONCLUSION: An intervention aimed at the hypertensive excessive drinkers in a working population was found to be effective in reducing SBP on a long term basis (two years). The mechanisms of reduction in alcohol consumption and improved drug compliance cannot be ascertained in this pragmatic study. From a public health point of view, reducing the excess cardiovascular risk among a "hard to reach" population seems feasible with a strategy specifically designed for this high risk group.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8596098      PMCID: PMC1060178          DOI: 10.1136/jech.49.6.610

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  30 in total

1.  Two-way factorial study of alcohol and salt restriction in treated hypertensive men.

Authors:  M Parker; I B Puddey; L J Beilin; R Vandongen
Journal:  Hypertension       Date:  1990-10       Impact factor: 10.190

2.  Analysis of data arising from a stratified design with the cluster as unit of randomization.

Authors:  A Donner; A Donald
Journal:  Stat Med       Date:  1987 Jan-Feb       Impact factor: 2.373

3.  Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men. A randomized controlled trial.

Authors:  I B Puddey; L J Beilin; R Vandongen; I L Rouse; P Rogers
Journal:  Hypertension       Date:  1985 Sep-Oct       Impact factor: 10.190

4.  Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies.

Authors:  A R Dyer; J Stamler; O Paul; D M Berkson; M H Lepper; H McKean; R B Shekelle; H A Lindberg; D Garside
Journal:  Circulation       Date:  1977-12       Impact factor: 29.690

5.  The effect of general practitioners' advice to heavy drinking men.

Authors:  P Anderson; E Scott
Journal:  Br J Addict       Date:  1992-06

6.  Relationship between alcohol consumption and hypertension prevalence and control in a French population.

Authors:  T Lang; P Degoulet; F Aime; C Devries; M C Jacquinet-Salord; C Fouriaud
Journal:  J Chronic Dis       Date:  1987

7.  Screening for alcohol abuse using the CAGE questionnaire.

Authors:  B Bush; S Shaw; P Cleary; T L Delbanco; M D Aronson
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

8.  Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial.

Authors:  I B Puddey; L J Beilin; R Vandongen
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

9.  Blood pressure measurement in adults: large cuffs for all?

Authors:  P R Croft; J K Cruickshank
Journal:  J Epidemiol Community Health       Date:  1990-06       Impact factor: 3.710

10.  Alcohol and cardiovascular disease: the status of the U shaped curve.

Authors:  M Marmot; E Brunner
Journal:  BMJ       Date:  1991-09-07
View more
  18 in total

1.  Risk estimation for hypertension based on follow-up health examination data in a small village in Kumamoto prefecture, Japan.

Authors:  M Shono; T Kitano; M Futatsuka
Journal:  Environ Health Prev Med       Date:  1997-01       Impact factor: 3.674

Review 2.  The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis.

Authors:  Michael Roerecke; Janusz Kaczorowski; Sheldon W Tobe; Gerrit Gmel; Omer S M Hasan; Jürgen Rehm
Journal:  Lancet Public Health       Date:  2017-02-07

3.  Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  N R Campbell; M J Ashley; S G Carruthers; Y Lacourcière; D W McKay
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 4.  Non-pharmacological aspects of blood pressure management: what are the data?

Authors:  S Susan Hedayati; Essam F Elsayed; Robert F Reilly
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

5.  Short-term outcomes in patients attending a primary care-based addiction shared care program.

Authors:  Meldon Kahan; Lynn Wilson; Deana Midmer; Alice Ordean; Heeyung Lim
Journal:  Can Fam Physician       Date:  2009-11       Impact factor: 3.275

6.  Impact of performance improvement continuing medical education on cardiometabolic risk factor control: the COSEHC initiative.

Authors:  JaNae Joyner; Michael A Moore; Debra R Simmons; Brian Forrest; Kristina Yu-Isenberg; Ron Piccione; Kirt Caton; Daniel T Lackland; Carlos M Ferrario
Journal:  J Contin Educ Health Prof       Date:  2014       Impact factor: 1.355

7.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

8.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

Review 10.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.